BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 32140069)

  • 1. Knockdown of SMAD3 inhibits the growth and enhances the radiosensitivity of lung adenocarcinoma via p21
    Niu H; Huang Y; Yan L; Zhang L; Zhao M; Lu T; Yang X; Chen Z; Zhan C; Shi Y; Wang Q
    Int J Biol Sci; 2020; 16(6):1010-1022. PubMed ID: 32140069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DMBX1 promotes tumor proliferation and regulates cell cycle progression via repressing OTX2-mediated transcription of p21 in lung adenocarcinoma cell.
    Luo J; Liu K; Yao Y; Sun Q; Zheng X; Zhu B; Zhang Q; Xu L; Shen Y; Ren B
    Cancer Lett; 2019 Jul; 453():45-56. PubMed ID: 30928384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HCP5 is a SMAD3-responsive long non-coding RNA that promotes lung adenocarcinoma metastasis via miR-203/SNAI axis.
    Jiang L; Wang R; Fang L; Ge X; Chen L; Zhou M; Zhou Y; Xiong W; Hu Y; Tang X; Li G; Li Z
    Theranostics; 2019; 9(9):2460-2474. PubMed ID: 31131047
    [No Abstract]   [Full Text] [Related]  

  • 4. Long Noncoding RNA CRNDE/PRC2 Participated in the Radiotherapy Resistance of Human Lung Adenocarcinoma Through Targeting p21 Expression.
    Zhang M; Gao C; Yang Y; Li G; Dong J; Ai Y; Chen N; Li W
    Oncol Res; 2018 Sep; 26(8):1245-1255. PubMed ID: 28550688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-cell transcriptomic sequencing data reveal aberrant DNA methylation in SMAD3 promoter region in tumor-associated fibroblasts affecting molecular mechanism of radiosensitivity in non-small cell lung cancer.
    Han F; Chen S; Zhang K; Zhang K; Wang M; Wang P
    J Transl Med; 2024 Mar; 22(1):288. PubMed ID: 38493128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The long noncoding RNA HOTAIR contributes to cisplatin resistance of human lung adenocarcinoma cells via downregualtion of p21(WAF1/CIP1) expression.
    Liu Z; Sun M; Lu K; Liu J; Zhang M; Wu W; De W; Wang Z; Wang R
    PLoS One; 2013; 8(10):e77293. PubMed ID: 24155936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knockdown of LINC00511 enhances radiosensitivity of lung adenocarcinoma via regulating miR-497-5p/SMAD3.
    Li C; Fu Y; He Y; Huang N; Yue J; Miao Y; Lv J; Xiao Y; Deng R; Zhang C; Huang M
    Cancer Biol Ther; 2023 Dec; 24(1):2165896. PubMed ID: 36861928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bmi-1-shRNA inhibits the proliferation of lung adenocarcinoma cells by blocking the G1/S phase through decreasing cyclin D1 and increasing p21/p27 levels.
    Zheng X; Wang Y; Liu B; Liu C; Liu D; Zhu J; Yang C; Yan J; Liao X; Meng X; Yang H
    Nucleic Acid Ther; 2014 Jun; 24(3):210-6. PubMed ID: 24552182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Knockdown of STIM1 expression inhibits non-small-cell lung cancer cell proliferation
    Ge C; Zeng B; Li R; Li Z; Fu Q; Wang W; Wang Z; Dong S; Lai Z; Wang Y; Xue Y; Guo J; Di T; Song X
    Bioengineered; 2019 Dec; 10(1):425-436. PubMed ID: 31564210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TGF-β/SMAD3 Pathway Stimulates Sphingosine-1 Phosphate Receptor 3 Expression: IMPLICATION OF SPHINGOSINE-1 PHOSPHATE RECEPTOR 3 IN LUNG ADENOCARCINOMA PROGRESSION.
    Zhao J; Liu J; Lee JF; Zhang W; Kandouz M; VanHecke GC; Chen S; Ahn YH; Lonardo F; Lee MJ
    J Biol Chem; 2016 Dec; 291(53):27343-27353. PubMed ID: 27856637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Knockdown of PTTG1 inhibits the growth and invasion of lung adenocarcinoma cells through regulation of TGFB1/SMAD3 signaling.
    Li WH; Chang L; Xia YX; Wang L; Liu YY; Wang YH; Jiang Z; Xiao J; Wang ZR
    Int J Immunopathol Pharmacol; 2015 Mar; 28(1):45-52. PubMed ID: 25816405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Membrane-Bound CD40L Promotes Senescence and Initiates Senescence-Associated Secretory Phenotype via NF-κB Activation in Lung Adenocarcinoma.
    Xu W; Li Y; Yuan WW; Yin Y; Song WW; Wang Y; Huang QQ; Zhao WH; Wu JQ
    Cell Physiol Biochem; 2018; 48(4):1793-1803. PubMed ID: 30078020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SOX6 suppresses the development of lung adenocarcinoma by regulating expression of p53, p21
    Lv L; Zhou M; Zhang J; Liu F; Qi L; Zhang S; Bi Y; Yu Y
    FEBS Open Bio; 2020 Jan; 10(1):135-146. PubMed ID: 31729835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Smad3 Promotes Cancer-Associated Fibroblasts Generation via Macrophage-Myofibroblast Transition.
    Tang PC; Chung JY; Xue VW; Xiao J; Meng XM; Huang XR; Zhou S; Chan AS; Tsang AC; Cheng AS; Lee TL; Leung KT; Lam EW; To KF; Tang PM; Lan HY
    Adv Sci (Weinh); 2022 Jan; 9(1):e2101235. PubMed ID: 34791825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RAB26 contributes to the progression of non-small cell lung cancer after being transcriptionally activated by SMAD3.
    Ren H; Yang B; Li M; Lu C; Li X
    Bioengineered; 2022 Apr; 13(4):8064-8075. PubMed ID: 35291909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synaptotagmin 12 (SYT12) Gene Expression Promotes Cell Proliferation and Progression of Lung Adenocarcinoma and Involves the Phosphoinositide 3-Kinase (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) Pathway.
    Liu K; Luo J; Shao C; Ren Z; Sun S; Zhu Y; Zhou H; Jiang Z; Li X; Gu W; Xu Y; Qiang Y; Ren B; Xu L; Wu H; Shen Y
    Med Sci Monit; 2020 Feb; 26():e920351. PubMed ID: 32108133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The miR-92b functions as a potential oncogene by targeting on Smad3 in glioblastomas.
    Wu ZB; Cai L; Lin SJ; Lu JL; Yao Y; Zhou LF
    Brain Res; 2013 Sep; 1529():16-25. PubMed ID: 23892108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-206 suppresses TGF-β signalling to limit tumor growth and metastasis in lung adenocarcinoma.
    Watt K; Newsted D; Voorand E; Gooding RJ; Majewski A; Truesdell P; Yao B; Tuschl T; Renwick N; Craig AW
    Cell Signal; 2018 Oct; 50():25-36. PubMed ID: 29935234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long non-coding RNA LINC01133 represses KLF2, P21 and E-cadherin transcription through binding with EZH2, LSD1 in non small cell lung cancer.
    Zang C; Nie FQ; Wang Q; Sun M; Li W; He J; Zhang M; Lu KH
    Oncotarget; 2016 Mar; 7(10):11696-707. PubMed ID: 26840083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIST1H3D: A promising therapeutic target for lung cancer.
    Rui Y; Peng WJ; Wang M; Wang Q; Liu ZL; Chen YQ; Huang LN
    Int J Oncol; 2017 Mar; 50(3):815-822. PubMed ID: 28112369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.